as on December 5, 2025 at 8:41 pm IST
Day's Low
Day's High
2.33%
Downside
7.51%
Upside
52 Week's Low
52 Week's High
83.85%
Downside
51.60%
Upside
Check Capricor Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.4B
EPS (TTM)
-2.1338
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-84.9M
Revenue (TTM)
11.1M
Profit Margin
0.00%
Return On Equity TTM
-107.79%
Compare market cap, revenue, PE, and other key metrics of Capricor Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.4B | 456.88% | NA | 0.00% | |
| BUY | $43.7B | 410.81% | -16.34 | -264.83% | |
| BUY | $62.5B | 258.57% | 1690.32 | 1.36% | |
| BUY | $118.7B | 100.27% | 30.49 | 31.35% | |
| BUY | $76.7B | 46.78% | 17.33 | 32.13% |
The Capricor Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Capricor Therapeutics Inc investment value today
Current value as on today
₹1,89,421
Returns
₹89,421
(+89.42%)
Returns from Capricor Therapeutics Inc Stock
₹83,276 (+83.28%)
Dollar Returns*
₹6,146 (+6.15%)
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Capricor Therapeutics Inc. Average target price of $20.7
Get share price movements and forecasts by analysts on Capricor Therapeutics Inc.
What analysts predicted
-28.65%DOWNSIDE
Target Price
$20.7
Current Price
$26.63
Analyzed by
10 Analysts
Target
$20.70
Capricor Therapeutics Inc target price $20.7, a slight downside of -28.65% compared to current price of $26.63. According to 10 analysts rating.
Investment in Capricor Therapeutics Inc Shares on INDmoney has grown by 1628.57% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:1628.57% versus previous 30 day period
Search interest for Capricor Therapeutics Inc Stock has increased by 1509% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1509% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 03 December
Wed, 08:33 PM
-Capricor shares surged 441% after positive topline results from Phase 3 HOPE-3 Trial for deramiocel therapy.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, CAPR stock has moved up by 376.7%
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 2.26M → 11.13M (in $), with an average increase of 79.7% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -25.91M → -24.57M (in $), with an average increase of 5.5% per quarter
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 930.9% return, outperforming this stock by 420.7%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 172.2% return, outperforming this stock by 96.7%
| Organisation | Capricor Therapeutics Inc |
| Headquarters | 10865 Road to the Cure, San Diego, CA, United States, 92121 |
| Industry | Health Technology |
| CEO | Dr. Linda Marbán Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Minghao Sun Ph.D. | Senior Vice President of Quality Control, Research & Product Development |
Mr. Mark Awadalla | Chief Development Officer |
Catherine Lee Kelleher M.D. | Consultant |
Dr. Frank Isaac Litvack FACC, M.D. | Executive Chairman of the Board |
Mr. Anthony J. Bergmann M.B.A. | CFO & Corporate Treasurer |
Dr. Kristi A. H. Elliott Ph.D. | Chief Operating & Science Officer |
Dr. Micheal Binks M.D. | Chief Medical Officer |
Dr. Linda Marbán Ph.D. | Co-Founder, President, CEO & Director |
Ms. Karen G. Krasney Esq., J.D. | Executive VP, General Counsel & Secretary |
Capricor Therapeutics Inc share price today is $26.63 as on . Capricor Therapeutics Inc share today touched a day high of $28.63 and a low of $26.01.
Capricor Therapeutics Inc share touched a 52 week high of $40.37 on and a 52 week low of $4.3 on . Capricor Therapeutics Inc stock price today i.e. is trending at $26.63,which is 34.04% down from its 52 week high and 519.30% up from its 52 week low.
Capricor Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Capricor Therapeutics Inc (CAPR) shares with as little as ₹89.927 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.27 in Capricor Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Capricor Therapeutics Inc share’s latest price of $26.63 as on December 5, 2025 at 8:41 pm IST, you will get 0.3755 shares of Capricor Therapeutics Inc. Learn more about
fractional shares .
Capricor Therapeutics Inc stock has given 456.88% share price returns and 21.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?